452 related articles for article (PubMed ID: 16517171)
1. Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist.
Van der Mey M; Windhorst AD; Klok RP; Herscheid JD; Kennis LE; Bischoff F; Bakker M; Langlois X; Heylen L; Jurzak M; Leysen JE
Bioorg Med Chem; 2006 Jul; 14(13):4526-34. PubMed ID: 16517171
[TBL] [Abstract][Full Text] [Related]
2. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.
Millan MJ; Maiofiss L; Cussac D; Audinot V; Boutin JA; Newman-Tancredi A
J Pharmacol Exp Ther; 2002 Nov; 303(2):791-804. PubMed ID: 12388666
[TBL] [Abstract][Full Text] [Related]
3. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
4. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
[TBL] [Abstract][Full Text] [Related]
5. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
[TBL] [Abstract][Full Text] [Related]
6. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
7. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile.
Millan MJ; Gobert A; Newman-Tancredi A; Lejeune F; Cussac D; Rivet JM; Audinot V; Adhumeau A; Brocco M; Nicolas JP; Boutin JA; Despaux N; Peglion JL
J Pharmacol Exp Ther; 2000 Jan; 292(1):38-53. PubMed ID: 10604930
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.
Lucatelli C; Honer M; Salazar JF; Ross TL; Schubiger PA; Ametamey SM
Nucl Med Biol; 2009 Aug; 36(6):613-22. PubMed ID: 19647167
[TBL] [Abstract][Full Text] [Related]
9. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization and autoradiographic distribution of alpha2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain.
Díez-Alarcia R; Pilar-Cuéllar F; Paniagua MA; Meana JJ; Fernández-López A
Neuroscience; 2006 Aug; 141(1):357-69. PubMed ID: 16697114
[TBL] [Abstract][Full Text] [Related]
11. Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization.
Millan MJ; Cussac D; Milligan G; Carr C; Audinot V; Gobert A; Lejeune F; Rivet JM; Brocco M; Duqueyroix D; Nicolas JP; Boutin JA; Newman-Tancredi A
J Pharmacol Exp Ther; 2001 Jun; 297(3):876-87. PubMed ID: 11356907
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biodistribution of [(11)C]R116301, a promising PET ligand for central NK(1) receptors.
Van der Mey M; Janssen CG; Janssens FE; Jurzak M; Langlois X; Sommen FM; Verreet B; Windhorst AD; Leysen JE; Herscheid JD
Bioorg Med Chem; 2005 Mar; 13(5):1579-86. PubMed ID: 15698775
[TBL] [Abstract][Full Text] [Related]
13. [Ethyl-3H]RS-79948-197 alpha2-adrenoceptor autoradiography validation in alpha2-adrenoceptor knockout mice.
Fagerholm V; Philipp M; Hein L; Scheinin M
Eur J Pharmacol; 2004 Aug; 497(3):301-9. PubMed ID: 15336948
[TBL] [Abstract][Full Text] [Related]
14. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A
J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457
[TBL] [Abstract][Full Text] [Related]
15. Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand.
Airaksinen AJ; Jablonowski JA; van der Mey M; Barbier AJ; Klok RP; Verbeek J; Schuit R; Herscheid JD; Leysen JE; Carruthers NI; Lammertsma AA; Windhorst AD
Nucl Med Biol; 2006 Aug; 33(6):801-10. PubMed ID: 16934699
[TBL] [Abstract][Full Text] [Related]
16. Meperidine, remifentanil and tramadol but not sufentanil interact with alpha(2)-adrenoceptors in alpha(2A)-, alpha(2B)- and alpha(2C)-adrenoceptor knock out mice brain.
Höcker J; Weber B; Tonner PH; Scholz J; Brand PA; Ohnesorge H; Bein B
Eur J Pharmacol; 2008 Mar; 582(1-3):70-7. PubMed ID: 18234187
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation in rodents of [(123)I]-3-I-CO as a potential SPECT tracer for the serotonin 5-HT(2A) receptor.
Blanckaert PB; Burvenich I; Wyffels L; De Bruyne S; Moerman L; De Vos F
Nucl Med Biol; 2008 Nov; 35(8):861-7. PubMed ID: 19026947
[TBL] [Abstract][Full Text] [Related]
18. In vivo labeling of endothelin receptors with [(11)C]L-753,037: studies in mice and a dog.
Aleksic S; Szabo Z; Scheffel U; Ravert HT; Mathews WB; Kerenyi L; Rauseo PA; Gibson RE; Burns HD; Dannals RF
J Nucl Med; 2001 Aug; 42(8):1274-80. PubMed ID: 11483691
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole. A new class of highly selective alpha(1) adrenoceptor antagonists.
Balle T; Perregaard J; Ramirez MT; Larsen AK; Søby KK; Liljefors T; Andersen K
J Med Chem; 2003 Jan; 46(2):265-83. PubMed ID: 12519065
[TBL] [Abstract][Full Text] [Related]
20. Interaction of morphine but not fentanyl with cerebral alpha2-adrenoceptors in alpha2-adrenoceptor knockout mice.
Höcker J; Böhm R; Meybohm P; Gruenewald M; Renner J; Ohnesorge H; Scholz J; Bein B
J Pharm Pharmacol; 2009 Jul; 61(7):901-10. PubMed ID: 19589232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
